1-9 of 9
Jean Michel Karsenti, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Jérôme Paillassa, MD, Edouard Cornet, MD, Stephanie Noel, Cecile Tomowiak, Aline Schmidt, MD, Stephane Lepretre, Sandrine Vaudaux, Jehan Dupuis, MD, Alain Devidas, MD, Joly Bertrand, MD, Charlotte Petitditdier, MD, Stéphanie Haiat, Clara Mariette, MD, Catherine Thieblemont, MD PhD, Didier Decaudin, Bernard Drenou, MD, Jean Claude Eisenmann, MD, Mario Ojeda, MD, Agnès Olivrie, MD, Marie-Pierre Gourin, Olivier Lambotte, Olivier Hermine, MD PhD, Jean Michel Karsenti, MD, Pierre Feugier, MD PhD, Willy Vaillant, Jean Gutnecht, MD, Eric Lippert, MD PhD, Fabienne Huysman, MD, Kamel Ghomari, Marouane Boubaya, PhD, Vincent Levy, MD PhD, Jérémie Riou, PhD, Gandhi Damaj, MD PhD, Mathilde Hunault, MD PhD, Xavier Troussard, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1537.
https://doi.org/10.1182/blood-2019-127560
Published: 2019
Journal Articles

Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment

Anne Calleja, Chimene Moreilhon, PhD, Jean Michel Karsenti, MD, Lauris Gastaud, MD, Lionel Mannone, MD, Berengere Dadone, MD, Guillaume Robert, PhD, Patrick Auberger, PhD, Sophie Raynaud, MD PhD, Thomas Cluzeau, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5297.
https://doi.org/10.1182/blood.V130.Suppl_1.5297.5297
Published: 2017
Journal Articles

BCL2L10 Quantification Is a Predictive Factor of Response to Azacitidine in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Valerie Vidal, Clemence Ginet, Jean Michel Karsenti, MD, Frederic Luciano, PhD, Lauris Gastaud, MD, Georges Garnier, MD, Thorsten Braun, MD, Pierre Hirsch, MD, Emmanuel Raffoux, MD, Anne Marie Nloga, Herve Dombret, MD, Pierre-Simon Rohrlich, Lionel Ades, MD PhD, Christine Chomienne, MD PhD, Pierre Fenaux, MD PhD, Patrick Auberger, PhD, Guillaume Robert, PhD, Thomas Cluzeau, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3261.
https://doi.org/10.1182/blood.V124.21.3261.3261
Published: 2014
Journal Articles

Evaluation Of Acadesine, a Drug Stimulating Cell Autophagy, In Azacitidine(AZA)-Resistant Myelodysplastic Syndromes (MDS)

Thomas Cluzeau, MD, PhD, Guillaume Robert, PhD, Jean Michel Karsenti, MD, Frederic Luciano, PhD, Nicolas Mounier, MD, PhD, Jill Patrice Cassuto, MD, PhD, Lionel Ades, Sophie Raynaud, MD, PhD, Pierre Fenaux, MD, PhD, Patrick Auberger, PhD
Journal: Blood
Blood (2013) 122 (21): 1568.
https://doi.org/10.1182/blood.V122.21.1568.1568
Published: 2013
Journal Articles

Azacitidine Overcomes Prognosis Impact of Poor and Very Poor IPSS-Revised in RAEB-2 Patients but Not in AML Patients.

Thomas Cluzeau, MD, PhD, Nicolas Mounier, MD, PhD, Valentine Richez, Jean-Michel Karsenti, MD, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Henri Vinti, MD, Laurence Legros, MD, PhD, Lauris Gastaud, Antoine Thyss, MD, Georges Garnier, MD, Daniel Re, MD, Nathalie Montagne, MD, Jean Gutnecht, MD, Patrick Auberger, MD, PhD, Sophie Raynaud, Jill-Patrice Cassuto, MD
Journal: Blood
Blood (2012) 120 (21): 2813.
https://doi.org/10.1182/blood.V120.21.2813.2813
Published: 2012
Journal Articles

Tyrosine Kinase Inhibitor-Mediated Apoptosis Is Potentiated by FasL and Increased with IFN-α in Chronic Myeloid Leukemia

Laurence Legros, MD, PhD, Nathalie Ebran, PhD, Jean-Michel Karsenti, MD, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Nicolas Mounier, MD, PhD, Henri Vinti, MD, Jill-Patrice Cassuto, MD, Pierre-Simon Rohrlich, MD, PhD, Anne-Odile Hueber, PhD
Journal: Blood
Blood (2012) 120 (21): 4428.
https://doi.org/10.1182/blood.V120.21.4428.4428
Published: 2012
Journal Articles

Total Genomic Loss Detected by High-Density Single Nucleotide Polymorphism Array Is Predictive of Azacitidine Response in Very Poor IPSS-Revised MDS or AML Patients

Thomas Cluzeau, MD, PhD, Chimène Moreilhon, Nicolas Mounier, MD, PhD, Jean-Michel Karsenti, MD, Lionel Mannone, MD, Faezeh Legrand, MD, PhD, Valentine Richez, Lauris Gastaud, Antoine Thyss, MD, Georges Garnier, MD, Daniel Re, MD, Nathalie Montagne, MD, Jean Gutnecht, MD, Patrick Auberger, MD, PhD, Jill-Patrice Cassuto, MD, Sophie Raynaud
Journal: Blood
Blood (2012) 120 (21): 4936.
https://doi.org/10.1182/blood.V120.21.4936.4936
Published: 2012
Journal Articles

BCL2L10 (Bcl-B) Is Associated with Resistance to Azacitidine (AZA) in MDS and AML, and Is a Possible Therapeutic Target in AZA Resistant Patients

Thomas Cluzeau, MD, PhD, Guillaume Robert, Jean-Michel Karsenti, MD, Frederic Luciano, Alexandre Puissant, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Aline Renneville, MD, Claude Preudhomme, Pierre Fenaux, MD, PhD, Jill-Patrice Cassuto, MD, Sophie Raynaud, Nicolas Mounier, MD, PhD, Patrick Auberger, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 701.
https://doi.org/10.1182/blood.V120.21.701.701
Published: 2012
Journal Articles

Single 4-Dose Rituximab Treatment for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with a Follow-Up (F/Up) of at Least 5 Years.

Philippe Solal-Celigny, MD, PhD, Gilles Andre Salles, MD, PhD, Nicole Brousse, MD, Patricia Franchi-Rezgui, MD, Pierre Soubeyran, MD, PhD, Vincent Delwail, MD, Eric Deconinck, MD, Corinne Haioun, MD, PhD, Charles Foussard, MD, Catherine Sebban, MD, Herve Tilly, MD, PhD, Noel-Jean Milpied, MD, PhD, Francois Boue, MD, Jean-Michel Karsenti, MD, Pierre Lederlin, MD, PhD, Albert Najman, MD, Catherine Thieblemont, MD, PhD, Franck Morschhauser, MD, Nathalie Berriot-Varoqueaux, MD, PhD, Loic Bergougnoux, Philippe Colombat, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 585.
https://doi.org/10.1182/blood.V104.11.585.585
Published: 2004